DK0511917T3 - Glycosylerede prodrugs, fremgangsmåde til fremstilling deraf og anvendelse deraf - Google Patents
Glycosylerede prodrugs, fremgangsmåde til fremstilling deraf og anvendelse derafInfo
- Publication number
- DK0511917T3 DK0511917T3 DK92401218.0T DK92401218T DK0511917T3 DK 0511917 T3 DK0511917 T3 DK 0511917T3 DK 92401218 T DK92401218 T DK 92401218T DK 0511917 T3 DK0511917 T3 DK 0511917T3
- Authority
- DK
- Denmark
- Prior art keywords
- processes
- preparation
- glycosylated prodrugs
- prodrugs
- glycosylated
- Prior art date
Links
- 229940002612 prodrug Drugs 0.000 title abstract 3
- 239000000651 prodrug Substances 0.000 title abstract 3
- 206010028980 Neoplasm Diseases 0.000 abstract 2
- 229940045799 anthracyclines and related substance Drugs 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/20—Carbocyclic rings
- C07H15/203—Monocyclic carbocyclic rings other than cyclohexane rings; Bicyclic carbocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/20—Carbocyclic rings
- C07H15/24—Condensed ring systems having three or more rings
- C07H15/252—Naphthacene radicals, e.g. daunomycins, adriamycins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/26—Acyclic or carbocyclic radicals, substituted by hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9105326A FR2676058B1 (fr) | 1991-04-30 | 1991-04-30 | Prodrogues glycosylees, leur procede de preparation et leur utilisation dans le traitement des cancers. |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0511917T3 true DK0511917T3 (da) | 1997-04-01 |
Family
ID=9412404
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK92401218.0T DK0511917T3 (da) | 1991-04-30 | 1992-04-29 | Glycosylerede prodrugs, fremgangsmåde til fremstilling deraf og anvendelse deraf |
Country Status (16)
Country | Link |
---|---|
US (1) | US5561119A (uk) |
EP (1) | EP0511917B1 (uk) |
JP (1) | JP3053646B2 (uk) |
KR (1) | KR100254113B1 (uk) |
AT (1) | ATE144523T1 (uk) |
AU (1) | AU673138B2 (uk) |
CA (1) | CA2109304C (uk) |
DE (1) | DE69214712T2 (uk) |
DK (1) | DK0511917T3 (uk) |
ES (1) | ES2096735T3 (uk) |
FR (1) | FR2676058B1 (uk) |
GR (1) | GR3022344T3 (uk) |
HK (1) | HK1008020A1 (uk) |
IE (1) | IE921369A1 (uk) |
UA (1) | UA56981C2 (uk) |
WO (1) | WO1992019639A1 (uk) |
Families Citing this family (73)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6610299B1 (en) * | 1989-10-19 | 2003-08-26 | Aventis Pharma Deutschland Gmbh | Glycosyl-etoposide prodrugs, a process for preparation thereof and the use thereof in combination with functionalized tumor-specific enzyme conjugates |
US6475486B1 (en) * | 1990-10-18 | 2002-11-05 | Aventis Pharma Deutschland Gmbh | Glycosyl-etoposide prodrugs, a process for preparation thereof and the use thereof in combination with functionalized tumor-specific enzyme conjugates |
DE4236237A1 (de) * | 1992-10-27 | 1994-04-28 | Behringwerke Ag | Prodrugs, ihre Herstellung und Verwendung als Arzneimittel |
EP0647450A1 (en) * | 1993-09-09 | 1995-04-12 | BEHRINGWERKE Aktiengesellschaft | Improved prodrugs for enzyme mediated activation |
ES2148259T3 (es) * | 1993-09-22 | 2000-10-16 | Hoechst Ag | Pro-profarmacos, su produccion y uso. |
FR2712888B1 (fr) * | 1993-11-23 | 1996-02-09 | Bioeurope | Utilisation de alpha-D-alkylglucopyranosides et esters de ceux-ci pour la préparation de prodrogues capables de traverser la barrière hématoencéphalique, prodrogues obtenues et précurseurs de celles-ci. |
DE4417865A1 (de) * | 1994-05-20 | 1995-11-23 | Behringwerke Ag | Kombination von Tumornekrose-induzierenden Substanzen mit Substanzen, die durch Nekrosen aktiviert werden, zur selektiven Tumortherapie |
US5525606A (en) | 1994-08-01 | 1996-06-11 | The United States Of America As Represented By The Department Of Health And Human Services | Substituted 06-benzylguanines and 6(4)-benzyloxypyrimidines |
DE19512484A1 (de) | 1995-04-04 | 1996-10-17 | Bayer Ag | Kohlenhydratmodifizierte Cytostatika |
DE69533615T2 (de) * | 1995-06-27 | 2005-10-13 | Pharmachemie B.V. | Anthracyclin Prodrugs, Verfahren zu deren Herstellung und deren Verwendung in der selektiven Chemotherapie |
SI0795334T1 (sl) * | 1996-03-12 | 2006-06-30 | Sanofi Aventis Deutschland | Predzdravila za zdravljenje tumorjev in vnetnih bolezni |
DE19617851A1 (de) | 1996-05-03 | 1997-11-13 | Hoechst Ag | Nukleinsäurekonstrukte mit Genen kodierend für Transportsignale |
GB2318471A (en) * | 1996-10-18 | 1998-04-22 | Stc Submarine Systems Ltd | Semiconductor laser amplifiers for transient suppression in optical wavelength division multiplex networks |
DE19720312A1 (de) * | 1997-05-15 | 1998-11-19 | Hoechst Ag | Zubereitung mit erhöhter in vivo Verträglichkeit |
DE19751587A1 (de) | 1997-11-21 | 1999-07-29 | Hoechst Marion Roussel De Gmbh | Onkogen- oder virusgesteuerte Expressionssysteme |
AU1825299A (en) | 1997-12-17 | 1999-07-05 | Enzon, Inc. | Polymeric prodrugs of amino- and hydroxyl-containing bioactive agents |
US6180095B1 (en) | 1997-12-17 | 2001-01-30 | Enzon, Inc. | Polymeric prodrugs of amino- and hydroxyl-containing bioactive agents |
US6624142B2 (en) | 1997-12-30 | 2003-09-23 | Enzon, Inc. | Trimethyl lock based tetrapartate prodrugs |
US5965119A (en) * | 1997-12-30 | 1999-10-12 | Enzon, Inc. | Trialkyl-lock-facilitated polymeric prodrugs of amino-containing bioactive agents |
US6962702B2 (en) | 1998-06-22 | 2005-11-08 | Immunomedics Inc. | Production and use of novel peptide-based agents for use with bi-specific antibodies |
US6214330B1 (en) | 1998-07-13 | 2001-04-10 | Enzon, Inc. | Coumarin and related aromatic-based polymeric prodrugs |
US6043367A (en) * | 1998-09-30 | 2000-03-28 | Roffler; Steve | Proactive antitumor compounds |
US6413507B1 (en) * | 1999-12-23 | 2002-07-02 | Shearwater Corporation | Hydrolytically degradable carbamate derivatives of poly (ethylene glycol) |
US7220824B1 (en) | 2000-08-28 | 2007-05-22 | Bayer Aktiengesellschaft | Integrin-mediated drug targeting |
US6436386B1 (en) | 2000-11-14 | 2002-08-20 | Shearwater Corporation | Hydroxyapatite-targeting poly (ethylene glycol) and related polymers |
US7829074B2 (en) | 2001-10-18 | 2010-11-09 | Nektar Therapeutics | Hydroxypatite-targeting poly(ethylene glycol) and related polymers |
EP1219634A1 (en) * | 2000-12-27 | 2002-07-03 | Bayer Aktiengesellschaft | Cytostatic-glycoconjugates having specifically cleavable peptidic linking units |
DK1362053T3 (da) * | 2001-02-20 | 2008-03-10 | Enzon Inc | Terminalt forgrenede polymere linkere og polymere konjugater indeholdende disse |
EP1238678A1 (en) * | 2001-03-08 | 2002-09-11 | Bayer Aktiengesellschaft | Enzyme-activated cytostatic conjugates with integrin ligands |
US7629309B2 (en) | 2002-05-29 | 2009-12-08 | Zystor Therapeutics, Inc. | Targeted therapeutic proteins |
US7560424B2 (en) | 2001-04-30 | 2009-07-14 | Zystor Therapeutics, Inc. | Targeted therapeutic proteins |
WO2003073988A2 (en) | 2002-02-28 | 2003-09-12 | A & D Bioscience, Inc. | Glycuronamides, glycosides and orthoester glycosides of fluoxetine, analogs and uses thereof |
US20050107310A1 (en) * | 2002-03-19 | 2005-05-19 | Holick Michael F. | Carboxylic acid glycuronides, glycosamides and glycosides of quinolones, penicillins, analogs, and uses thereof |
US20050255038A1 (en) * | 2002-04-12 | 2005-11-17 | A And D Bioscience, Inc. | Conjugates comprising cancer cell specific ligands, a sugar and diagnostic agents and uses thereof |
EP1549323A2 (en) * | 2002-05-07 | 2005-07-06 | A & D Bioscience, Inc. | Conjugates comprising central nervous system active drug |
US20050215487A1 (en) * | 2002-06-27 | 2005-09-29 | Holick Michael F | Conjugates comprising an nsaid and a sugar and uses thereof |
SI2269656T1 (sl) | 2002-07-15 | 2014-11-28 | Board Of Regents, The University Of Texas System | Izbrana protitelesa, ki se veĹľejo na aminofosfolipide, in njihova uporaba v zdravljanju raka |
US20040152769A1 (en) * | 2002-11-09 | 2004-08-05 | Ekwuribe Nnochiri Nkem | Modified carbamate-containing prodrugs and methods of synthesizing same |
DE10256982A1 (de) * | 2002-12-05 | 2004-06-24 | Schering Ag | Neue Effektor-Konjugate, Verfahren zu Ihrer Herstellung und Ihre Pharmazeutische Verwendung |
CA2534639C (en) | 2003-07-31 | 2013-07-30 | Immunomedics, Inc. | Anti-cd19 antibodies |
US7902338B2 (en) | 2003-07-31 | 2011-03-08 | Immunomedics, Inc. | Anti-CD19 antibodies |
AU2005282562A1 (en) * | 2004-09-08 | 2006-03-16 | Government Of The United States Of America Represented By The Secretary, Department Of Health And Human Services | Beta-glucuronidase cleavable prodrugs of O6-alkylguanine-DNA alkyltransferase inactivators |
US7825096B2 (en) * | 2004-09-08 | 2010-11-02 | The United States Of America As Represented By The Department Of Health And Human Services | O6-alkylguanine-DNA alkyltransferase inactivators and beta-glucuronidase cleavable prodrugs |
SI3248613T1 (sl) | 2005-07-18 | 2022-04-29 | Seagen Inc. | Konjugati beta-glukuronidni linker-zdravilo |
US20070185135A1 (en) * | 2005-12-30 | 2007-08-09 | Pharmaessentia Corp. | Drug-Polymer Conjugates |
US20100323976A1 (en) * | 2007-06-14 | 2010-12-23 | Johannes Maria Franciscus Gerardus Aerts | Novel anti-inflammatory pro-drugs |
JP5404624B2 (ja) * | 2007-08-01 | 2014-02-05 | カウンスィル オブ サイエンティフィック アンド インダストリアル リサーチ | 選択的な抗腫瘍薬として有用なピロロ[2,1−c][1,4]ベンゾジアゼピン−グリコシドプロドラッグ |
AU2008317383B2 (en) | 2007-10-23 | 2013-11-14 | Nektar Therapeutics | Hydroxyapatite-targeting multiarm polymers and conjugates made therefrom |
EP2614837A1 (en) | 2007-11-09 | 2013-07-17 | Affitech Research AS | Anti-VEGF antibody compositions and methods |
EP2098533A1 (en) * | 2008-03-07 | 2009-09-09 | Pharmachemie B.V. | Esters of glucuronide prodrugs of anthracyclines and method of preparation and use in tumor-selective chemotherapy |
BR122017015900A2 (pt) | 2008-05-07 | 2019-09-10 | Biomarin Pharm Inc | ácido nucleico e células |
WO2010146059A2 (en) | 2009-06-16 | 2010-12-23 | F. Hoffmann-La Roche Ag | Biomarkers for igf-1r inhibitor therapy |
EP3075386B1 (en) | 2009-06-17 | 2019-10-16 | BioMarin Pharmaceutical Inc. | Formulations for lysosomal enzymes |
FR2960153B1 (fr) | 2010-05-20 | 2012-08-17 | Centre Nat Rech Scient | Nouveaux bras autoreactifs et prodrogues les comprenant |
US9023813B2 (en) * | 2011-04-13 | 2015-05-05 | NuTek Pharma Ltd. | Synthesis and use of glycoside derivatives of propofol |
EP2825206A1 (en) | 2012-03-16 | 2015-01-21 | The Johns Hopkins University | Controlled release formulations for the delivery of hif-1 inhibitors |
CN109843919A (zh) | 2016-03-25 | 2019-06-04 | 西雅图基因公司 | 用于制备聚乙二醇化的药物-接头及其中间体的方法 |
GB201617466D0 (en) | 2016-10-14 | 2016-11-30 | Medimmune Ltd | Pyrrolobenzodiazepine conjugates |
GB201702031D0 (en) | 2017-02-08 | 2017-03-22 | Medlmmune Ltd | Pyrrolobenzodiazepine-antibody conjugates |
LT3544636T (lt) | 2017-02-08 | 2021-06-25 | Adc Therapeutics Sa | Pirolobenzodiazepino-antikūno konjugatai |
CN110430901A (zh) | 2017-03-24 | 2019-11-08 | 西雅图基因公司 | 制备葡糖苷酸药物-接头及其中间体的方法 |
HUE059828T2 (hu) | 2017-04-18 | 2023-01-28 | Medimmune Ltd | Pirrolobenzodiazepin konjugátumok |
AU2018316532B2 (en) | 2017-08-18 | 2022-11-24 | Medimmune Limited | Pyrrolobenzodiazepine conjugates |
GB201803342D0 (en) | 2018-03-01 | 2018-04-18 | Medimmune Ltd | Methods |
GB201806022D0 (en) | 2018-04-12 | 2018-05-30 | Medimmune Ltd | Pyrrolobenzodiazepines and conjugates thereof |
US20210386864A1 (en) | 2018-11-05 | 2021-12-16 | Bayer Pharma Aktiengesellschaft | Cytostatic conjugates with integrin ligands |
KR102258299B1 (ko) * | 2019-03-21 | 2021-05-28 | 고려대학교 산학협력단 | 대장암 선택적 항암 치료진단제 |
WO2021057840A1 (en) * | 2019-09-25 | 2021-04-01 | Peking University | Senolytic and antiinflammatory prodrugs and methods of use thereof |
WO2021056270A1 (en) * | 2019-09-25 | 2021-04-01 | Peking University | Senolytic prodrugs and methods of use thereof |
US20220362387A1 (en) * | 2019-09-25 | 2022-11-17 | Peking University | Senolytic and antiinflammatory prodrugs and methods of use thereof |
WO2023057812A1 (en) | 2021-10-04 | 2023-04-13 | Vincerx Pharma Gmbh | Compounds, pharmaceutical compositions, and methods for the treatment, prevention, or management of hyperproliferative disorder |
WO2023057813A1 (en) | 2021-10-04 | 2023-04-13 | Vincerx Pharma Gmbh | Compounds, pharmaceutical compositions, and methods for the treatment, prevention, or management of hyperproliferative disorders |
WO2023057814A1 (en) | 2021-10-04 | 2023-04-13 | Vincerx Pharma Gmbh | Compounds, pharmaceutical compositions, and methods for the treatment, prevention, or management of hyperproliferative disorders |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4035566A (en) * | 1975-09-25 | 1977-07-12 | Sidney Farber Cancer Institute, Inc. | N-trifluoroacetyladriamycin-14-alkanoates and therapeutic compositions containing same |
WO1981001145A1 (en) * | 1979-10-18 | 1981-04-30 | Univ Illinois | Hydrolytic enzyme-activatible pro-drugs |
GB8705477D0 (en) * | 1987-03-09 | 1987-04-15 | Carlton Med Prod | Drug delivery systems |
US4975278A (en) * | 1988-02-26 | 1990-12-04 | Bristol-Myers Company | Antibody-enzyme conjugates in combination with prodrugs for the delivery of cytotoxic agents to tumor cells |
US4952394A (en) * | 1987-11-23 | 1990-08-28 | Bristol-Myers Company | Drug-monoclonal antibody conjugates |
DK0454783T3 (da) * | 1989-01-23 | 1995-10-16 | Akzo Nobel Nv | Sted-specifik in vivo aktivering af terapeutiske lægemidler |
DE3924655A1 (de) * | 1989-07-26 | 1991-01-31 | Behringwerke Ag | Anthracyclin-derivate |
JPH075572B2 (ja) * | 1989-08-18 | 1995-01-25 | 積水化学工業株式会社 | 2―[2―(2―ヒドロキシフェニル)ビニルピラジンおよびその製造法 |
DE3935016A1 (de) * | 1989-10-20 | 1991-04-25 | Behringwerke Ag | Glycosyl-etoposid-prodrugs, verfahren zu ihrer herstellung und ihre anwendung in kombination mit funktionalisiertem tumorspezifischen enzym-konjugaten |
-
1991
- 1991-04-30 FR FR9105326A patent/FR2676058B1/fr not_active Expired - Fee Related
-
1992
- 1992-04-29 JP JP4509828A patent/JP3053646B2/ja not_active Expired - Lifetime
- 1992-04-29 EP EP92401218A patent/EP0511917B1/fr not_active Expired - Lifetime
- 1992-04-29 DK DK92401218.0T patent/DK0511917T3/da active
- 1992-04-29 KR KR1019930703288A patent/KR100254113B1/ko not_active IP Right Cessation
- 1992-04-29 AT AT92401218T patent/ATE144523T1/de active
- 1992-04-29 ES ES92401218T patent/ES2096735T3/es not_active Expired - Lifetime
- 1992-04-29 DE DE69214712T patent/DE69214712T2/de not_active Expired - Lifetime
- 1992-04-29 WO PCT/FR1992/000385 patent/WO1992019639A1/fr active Application Filing
- 1992-04-29 UA UA93003896A patent/UA56981C2/uk unknown
- 1992-04-29 CA CA002109304A patent/CA2109304C/en not_active Expired - Lifetime
- 1992-04-29 US US08/137,167 patent/US5561119A/en not_active Expired - Lifetime
- 1992-04-29 AU AU17788/92A patent/AU673138B2/en not_active Expired
- 1992-07-01 IE IE136992A patent/IE921369A1/en not_active IP Right Cessation
-
1997
- 1997-01-22 GR GR970400091T patent/GR3022344T3/el unknown
-
1998
- 1998-06-26 HK HK98107056A patent/HK1008020A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
FR2676058A1 (fr) | 1992-11-06 |
IE921369A1 (en) | 1992-11-04 |
JP3053646B2 (ja) | 2000-06-19 |
KR100254113B1 (ko) | 2000-04-15 |
ES2096735T3 (es) | 1997-03-16 |
GR3022344T3 (en) | 1997-04-30 |
ATE144523T1 (de) | 1996-11-15 |
UA56981C2 (uk) | 2003-06-16 |
AU1778892A (en) | 1992-12-21 |
DE69214712T2 (de) | 1997-05-07 |
EP0511917B1 (fr) | 1996-10-23 |
JPH06506687A (ja) | 1994-07-28 |
FR2676058B1 (fr) | 1994-02-25 |
HK1008020A1 (en) | 1999-04-30 |
AU673138B2 (en) | 1996-10-31 |
CA2109304C (en) | 2002-01-15 |
WO1992019639A1 (fr) | 1992-11-12 |
US5561119A (en) | 1996-10-01 |
EP0511917A1 (fr) | 1992-11-04 |
DE69214712D1 (de) | 1996-11-28 |
CA2109304A1 (en) | 1992-10-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0511917T3 (da) | Glycosylerede prodrugs, fremgangsmåde til fremstilling deraf og anvendelse deraf | |
DE69200837D1 (en) | 3-difluoromethylpyrazolcarboxamidfungizide. | |
NO922275D0 (no) | Aryletere, deres fremstilling og fremgangsmaate for behandling | |
NO910003L (no) | Vitamin e-derivater og fremgangsmaate for deres fremstilling. | |
ATE212540T1 (de) | Antitumorvakzine | |
AU628095B2 (en) | Chelants possessing ortho ligating functionality and complexes thereof | |
KR0156686B1 (en) | Pharmaceutical composition comprising aryl-substituted rhodanine derivatives | |
ATE190659T1 (de) | Rekombinante immuntoxine | |
DK0557199T3 (da) | Polyethylenglycol-hirudin-konjugater, fremgangsmåde til fremstilling deraf og anvendelse deraf til behandling af tromboser | |
FI852730L (fi) | (pyrrol-1-yl) -fenyl-dihydropyridazinoner, deras framstaellning och anvaendning. | |
NO911047D0 (no) | Labdaner og fremgangsmaate for deres fremstilling. | |
ZA891242B (en) | 24r-scymnol,and preparation and use thereof | |
EP0342427A3 (de) | Strobilurinderivate, ihre Herstellung und Verwendung | |
PT88294A (pt) | Processo para a preparacao de derivados de fenantridina | |
NO914766D0 (no) | Sakkaridsammensetninger, fremgangsmaater og apparatur for fremstilling derav | |
NO912759D0 (no) | Genproteinprodukter og fremgangsmaater for celleterapi. | |
ITMI912612A0 (it) | 5-nitro-1-metil-imidazolil-3-terbutil-2-idrossi-5-metossi-fenil- carbinolo,processo per prepararlo e relative composizioni terapautiche | |
ZW10192A1 (en) | Conjugates |